PFIZER INC Comprehensive Income
PFIZER INC (PFE) reported Comprehensive Income of -$263.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-28 was -$263.00M, a 108.61% decline year-over-year.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-29 was $3.55B, a 59.44% increase year-over-year.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.65B, a 406.88% decline year-over-year.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-28 was $3.91B, a 9.21% decline year-over-year.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $7.54B, a 7.42% decline from fiscal 2024.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $8.15B, a 230.99% increase from fiscal 2023.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $2.46B, a 91.50% decline from fiscal 2022.
- PFIZER INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $28.96B, a 35.39% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$263.00M 10-Q · filed 2026-08-04 | $3.29B 10-Q · filed 2026-08-04 | $1.64B derived: sum of 3 quarters · filed 2026-08-04 | $5.55B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-29 | $3.55B 10-Q · filed 2026-05-05 | $1.90B derived: sum of 2 quarters · filed 2026-05-05 | $5.82B derived: sum of 3 quarters · filed 2026-05-05 | $8.87B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | -$1.65B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.26B derived: sum of 2 quarters · filed 2026-02-26 | $5.32B derived: sum of 3 quarters · filed 2026-08-04 | $7.54B 10-K · filed 2026-02-26 | |||
| 2025-09-28 | $3.91B 10-Q · filed 2025-11-04 | $6.97B derived: sum of 2 quarters · filed 2026-08-04 | $9.20B 10-Q · filed 2025-11-04 | $9.73B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-29 | $3.05B 10-Q · filed 2026-08-04 | $5.28B 10-Q · filed 2026-08-04 | $5.82B derived: sum of 3 quarters · filed 2026-08-04 | $10.13B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-30 | $2.23B 10-Q · filed 2026-05-05 | $2.77B derived: sum of 2 quarters · filed 2026-05-05 | $7.08B derived: sum of 3 quarters · filed 2026-05-05 | $7.06B derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $538.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.85B derived: sum of 2 quarters · filed 2026-02-26 | $4.83B derived: sum of 3 quarters · filed 2026-02-26 | $8.15B 10-K · filed 2026-02-26 | |||
| 2024-09-29 | $4.31B 10-Q · filed 2025-11-04 | $4.29B derived: sum of 2 quarters · filed 2025-11-04 | $7.61B 10-Q · filed 2025-11-04 | $4.25B derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$17.00M 10-Q · filed 2025-08-05 | $3.30B 10-Q · filed 2025-08-05 | -$62.00M derived: sum of 3 quarters · filed 2026-02-26 | -$2.31B derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $3.32B 10-Q · filed 2025-05-05 | -$45.00M derived: sum of 2 quarters · filed 2026-02-26 | -$2.29B derived: sum of 3 quarters · filed 2026-02-26 | $222.00M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$3.36B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.61B derived: sum of 2 quarters · filed 2026-02-26 | -$3.10B derived: sum of 3 quarters · filed 2026-02-26 | $2.46B 10-K · filed 2026-02-26 | |||
| 2023-10-01 | -$2.25B 10-Q · filed 2024-11-04 | $267.00M derived: sum of 2 quarters · filed 2024-11-04 | $5.83B 10-Q · filed 2024-11-04 | $10.74B derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-07-02 | $2.51B 10-Q · filed 2024-08-05 | $8.07B 10-Q · filed 2024-08-05 | $12.99B derived: sum of 3 quarters · filed 2025-02-27 | $20.49B derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-04-02 | $5.56B 10-Q · filed 2024-05-08 | $10.47B derived: sum of 2 quarters · filed 2025-02-27 | $17.98B derived: sum of 3 quarters · filed 2025-02-27 | $26.92B derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $4.92B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.42B derived: sum of 2 quarters · filed 2025-02-27 | $21.36B derived: sum of 3 quarters · filed 2025-02-27 | $28.96B 10-K · filed 2025-02-27 | |||
| 2022-10-02 | $7.50B 10-Q · filed 2023-11-08 | $16.45B derived: sum of 2 quarters · filed 2023-11-08 | $24.05B 10-Q · filed 2023-11-08 | $27.20B derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-07-03 | $8.94B 10-Q · filed 2023-08-09 | $16.55B 10-Q · filed 2023-08-09 | $19.69B derived: sum of 3 quarters · filed 2024-02-22 | $26.95B derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-04-03 | $7.60B 10-Q · filed 2023-05-10 | $10.75B derived: sum of 2 quarters · filed 2024-02-22 | $18.00B derived: sum of 3 quarters · filed 2024-02-22 | $23.47B derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | $3.15B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $10.40B derived: sum of 2 quarters · filed 2024-02-22 | $15.87B derived: sum of 3 quarters · filed 2024-02-22 | $21.39B 10-K · filed 2024-02-22 | |||
| 2021-10-03 | $7.26B 10-Q · filed 2022-11-09 | $12.72B derived: sum of 2 quarters · filed 2022-11-09 | $18.25B 10-Q · filed 2022-11-09 | $19.89B derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-07-04 | $5.47B 10-Q · filed 2022-08-10 | $10.99B 10-Q · filed 2022-08-10 | $12.64B derived: sum of 3 quarters · filed 2023-02-23 | $15.40B derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-04-04 | $5.52B 10-Q · filed 2022-05-11 | $7.17B derived: sum of 2 quarters · filed 2023-02-23 | $9.94B derived: sum of 3 quarters · filed 2023-02-23 | $13.25B derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $1.65B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.41B derived: sum of 2 quarters · filed 2023-02-23 | $7.73B derived: sum of 3 quarters · filed 2023-02-23 | $9.64B 10-K · filed 2023-02-23 | |||
| 2020-09-27 | $2.77B 10-Q · filed 2021-11-12 | $2.76B 10-Q · filed 2020-11-05 | $6.08B derived: sum of 2 quarters · filed 2021-11-12 | $7.99B 10-Q · filed 2021-11-12 | $7.99B 10-Q · filed 2020-11-05 | $7.82B derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-28 | $3.31B 10-Q · filed 2021-08-12 | $3.31B 10-Q · filed 2020-08-06 | $5.23B 10-Q · filed 2021-08-12 | $5.22B 10-Q · filed 2020-08-06 | $5.05B derived: sum of 3 quarters · filed 2022-02-24 | $12.47B derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-29 | $1.91B 10-Q · filed 2021-05-13 | $1.91B 10-Q · filed 2020-05-07 | $1.74B derived: sum of 2 quarters · filed 2022-02-24 | $9.15B derived: sum of 3 quarters · filed 2022-02-24 | $13.59B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | -$176.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.24B derived: sum of 2 quarters · filed 2022-02-24 | $11.67B derived: sum of 3 quarters · filed 2022-02-24 | $15.91B 10-K · filed 2022-02-24 | |||
| 2019-09-29 | $7.42B 10-Q · filed 2020-11-05 | $11.85B derived: sum of 2 quarters · filed 2020-11-05 | $16.08B 10-Q · filed 2020-11-05 | $14.83B derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $4.43B 10-Q · filed 2020-08-06 | $8.67B 10-Q · filed 2020-08-06 | $7.42B derived: sum of 3 quarters · filed 2021-02-25 | $11.12B derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $4.24B 10-Q · filed 2020-05-07 | $2.98B derived: sum of 2 quarters · filed 2021-02-25 | $6.68B derived: sum of 3 quarters · filed 2021-02-25 | $9.95B derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.45B derived: sum of 2 quarters · filed 2021-02-25 | $5.72B derived: sum of 3 quarters · filed 2021-02-25 | $9.20B 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $3.70B 10-Q · filed 2019-11-07 | $6.97B derived: sum of 2 quarters · filed 2019-11-07 | $10.45B 10-Q · filed 2019-11-07 | $22.57B derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-07-01 | $3.27B 10-Q · filed 2019-08-08 | $6.75B 10-Q · filed 2019-08-08 | $18.87B derived: sum of 3 quarters · filed 2020-02-27 | $22.72B derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-04-01 | $3.48B 10-Q · filed 2019-05-09 | $15.60B derived: sum of 2 quarters · filed 2020-02-27 | $19.45B derived: sum of 3 quarters · filed 2020-02-27 | $22.94B derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2017-12-31 | $12.12B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $15.97B derived: sum of 2 quarters · filed 2020-02-27 | $19.46B derived: sum of 3 quarters · filed 2020-02-27 | $23.02B 10-K · filed 2020-02-27 | |||
| 2017-10-01 | $3.86B 10-Q · filed 2018-11-08 | $7.34B derived: sum of 2 quarters · filed 2018-11-08 | $10.91B 10-Q · filed 2018-11-08 | $8.86B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-07-02 | $3.49B 10-Q · filed 2018-08-09 | $7.05B 10-Q · filed 2018-08-09 | $5.00B derived: sum of 3 quarters · filed 2019-02-28 | $7.04B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-04-02 | $3.56B 10-Q · filed 2018-05-10 | $1.52B derived: sum of 2 quarters · filed 2019-02-28 | $3.55B derived: sum of 3 quarters · filed 2019-02-28 | $6.22B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$2.05B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$14.00M derived: sum of 2 quarters · filed 2019-02-28 | $2.66B derived: sum of 3 quarters · filed 2019-02-28 | $5.70B 10-K · filed 2019-02-28 | |||
| 2016-10-02 | $2.03B 10-Q · filed 2017-11-09 | $2.00B 10-Q · filed 2016-11-10 | $4.71B derived: sum of 2 quarters · filed 2017-11-09 | $7.75B 10-Q · filed 2017-11-09 | $7.66B 10-Q · filed 2016-11-10 | $7.22B derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-07-03 | $2.68B 10-Q · filed 2017-08-10 | $2.65B 10-Q · filed 2016-08-11 | $5.71B 10-Q · filed 2017-08-10 | $5.67B 10-Q · filed 2016-08-11 | $5.19B derived: sum of 3 quarters · filed 2018-02-22 | $6.67B derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-04-03 | $3.04B 10-Q · filed 2017-05-11 | $3.02B 10-Q · filed 2016-05-12 | $2.52B derived: sum of 2 quarters · filed 2018-02-22 | $4.00B derived: sum of 3 quarters · filed 2018-02-22 | $6.66B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2015-12-31 | -$523.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $958.00M derived: sum of 2 quarters · filed 2018-02-22 | $3.62B derived: sum of 3 quarters · filed 2018-02-22 | $4.75B 10-K · filed 2018-02-22 | |||
| 2015-09-27 | $1.48B 10-Q · filed 2016-11-10 | $4.14B derived: sum of 2 quarters · filed 2016-11-10 | $5.28B 10-Q · filed 2016-11-10 | $2.66B derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-28 | $2.66B 10-Q · filed 2016-08-11 | $3.80B 10-Q · filed 2016-08-11 | $1.18B derived: sum of 3 quarters · filed 2017-02-23 | $3.53B derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-29 | $1.13B 10-Q · filed 2016-05-12 | -$1.49B derived: sum of 2 quarters · filed 2017-02-23 | $864.00M derived: sum of 3 quarters · filed 2017-02-23 | $4.01B derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | -$2.62B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$270.00M derived: sum of 2 quarters · filed 2017-02-23 | $2.88B derived: sum of 3 quarters · filed 2017-02-23 | $5.09B 10-K · filed 2017-02-23 | |||
| 2014-09-28 | $2.35B 10-Q · filed 2015-11-05 | $5.50B derived: sum of 2 quarters · filed 2015-11-05 | $7.71B 10-Q · filed 2015-11-05 | $13.36B derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-29 | $3.15B 10-Q · filed 2015-08-06 | $5.36B 10-Q · filed 2015-08-06 | $11.01B derived: sum of 3 quarters · filed 2016-02-29 | $13.69B derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-30 | $2.21B 10-Q · filed 2015-05-07 | $7.86B derived: sum of 2 quarters · filed 2016-02-29 | $10.54B derived: sum of 3 quarters · filed 2016-02-29 | $24.32B derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $5.65B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $8.32B derived: sum of 2 quarters · filed 2016-02-29 | $22.11B derived: sum of 3 quarters · filed 2016-02-29 | $24.66B 10-K · filed 2016-02-29 | |||
| 2013-09-29 | $2.67B 10-Q · filed 2014-11-06 | $16.46B derived: sum of 2 quarters · filed 2014-11-06 | $19.00B 10-Q · filed 2014-11-06 | $25.02B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $13.79B 10-Q · filed 2014-08-07 | $16.33B 10-Q · filed 2014-08-07 | $22.35B derived: sum of 3 quarters · filed 2015-02-27 | $25.91B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $2.55B 10-Q · filed 2014-05-08 | $8.56B derived: sum of 2 quarters · filed 2015-02-27 | $12.13B derived: sum of 3 quarters · filed 2015-02-27 | $12.99B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $6.01B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $9.58B derived: sum of 2 quarters · filed 2015-02-27 | $10.45B derived: sum of 3 quarters · filed 2015-02-27 | $12.75B 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $3.56B 10-Q · filed 2013-11-08 | $4.43B derived: sum of 2 quarters · filed 2013-11-08 | $6.73B 10-Q · filed 2013-11-08 | $5.26B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-07-01 | $867.00M 10-Q · filed 2013-08-09 | $3.17B 10-Q · filed 2013-08-09 | $1.69B derived: sum of 3 quarters · filed 2014-02-28 | $5.17B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-04-01 | $2.30B 10-Q · filed 2013-05-10 | $827.00M derived: sum of 2 quarters · filed 2014-02-28 | $4.31B derived: sum of 3 quarters · filed 2014-02-28 | $8.02B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | -$1.47B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.01B derived: sum of 2 quarters · filed 2014-02-28 | $5.72B derived: sum of 3 quarters · filed 2014-02-28 | $9.32B 10-K · filed 2014-02-28 | |||
| 2011-10-02 | $3.48B 10-Q · filed 2012-11-09 | $7.19B derived: sum of 2 quarters · filed 2012-11-09 | $10.79B 10-Q · filed 2012-11-09 | $13.94B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-07-03 | $3.71B 10-Q · filed 2011-08-11 | $7.31B 10-Q · filed 2012-08-09 | $10.46B derived: sum of 3 quarters · filed 2013-02-28 | $12.04B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-04-03 | $3.60B 10-Q · filed 2012-05-10 | $6.75B derived: sum of 2 quarters · filed 2013-02-28 | $8.32B derived: sum of 3 quarters · filed 2013-02-28 | $8.34B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | $3.15B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $4.72B derived: sum of 2 quarters · filed 2013-02-28 | $4.73B derived: sum of 3 quarters · filed 2013-02-28 | $4.26B 10-K · filed 2013-02-28 | |||
| 2010-10-03 | $1.57B 10-Q · filed 2011-11-10 | $1.58B derived: sum of 2 quarters · filed 2011-11-10 | $1.12B 10-Q · filed 2011-11-10 | ||||
| 2010-07-04 | $10.00M 10-Q · filed 2011-08-11 | $9.00M 10-Q · filed 2010-08-12 | -$458.00M 10-Q · filed 2011-08-11 | ||||
| 2010-04-04 | -$468.00M 10-Q · filed 2011-05-12 | ||||||
| 2009-09-27 | $3.07B 10-Q · filed 2010-11-12 | $7.91B derived: sum of 2 quarters · filed 2010-11-12 | $10.54B 10-Q · filed 2010-11-12 | ||||
| 2009-06-28 | $4.85B 10-Q · filed 2010-08-12 | $7.47B 10-Q · filed 2010-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |